Evidence map›Paper›PMID 40396125›Full record

ArticleClinical, cosmetic and investigational dermatology2025

Improved Skin Lesion Segmentation in Dermoscopic Images Using Object Detection and Semantic Segmentation.

Takashi Nagaoka

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Takashi NagaokaDepartment of Computational Systems Biology, Faculty of Biology-Oriented Science and Technology, Kindai University, Kinokawa, Wakayama, Japan.ORCID 0000-0002-7460-5008

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lesion segmentation in dermoscopic images significantly enhances the diagnostic performance of AI-based classification models. However, conventional methods often require pixel-level annotations, which are resource-intensive and prone to errors caused by external artifacts, such as hair and skin markings. Methods: We propose a hybrid framework called SAM-enhanced YOLO, which integrates the Segment Anything Model (SAM) with You Only Look Once (YOLO) for precise pixel-level segmentation. This method combines YOLO's efficient lesion localization with SAM's advanced zero-shot segmentation capabilities. To further validate the framework, we compared it against traditional methods, including GrabCut and Otsu's thresholding, as well as SAM used without YOLO (SAM-only). For SAM-only, lesion segmentation was initialized at the image center to simulate a typical dermoscopic imaging setup. Results: SAM-enhanced YOLO demonstrated superior segmentation performance, achieving an Intersection over Union (IoU) of 0.738 and an F1-score (the harmonic mean of precision and recall) of 0.833, compared to 0.578 and 0.683 with SAM-only, respectively. This represents a 28% improvement in IoU and a 22% improvement in F1-score compared to SAM-only. The results were consistent across lesion shapes and contrast conditions, with SAM-enhanced YOLO exhibiting the lowest variability and highest robustness among the evaluated methods. Conclusion: By reducing the need for pixel-level annotations and outperforming both standalone SAM and traditional methods, SAM-enhanced YOLO provides a scalable and resource-efficient solution for dermoscopic lesion segmentation. This framework holds significant potential for improving diagnostic workflows in clinical and resource-limited settings.

Indexed as

dermoscopydigital imagingobject detectionsemantic segmentationskin lesion segmentation

Identifiers

PMID40396125
PMCPMC12089257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.